Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Biodiversity | 21 | 2022 | 37 | 8.360 |
Why?
|
Trees | 18 | 2023 | 22 | 5.760 |
Why?
|
Laparoscopy | 26 | 2020 | 145 | 5.280 |
Why?
|
Ecosystem | 17 | 2022 | 27 | 5.130 |
Why?
|
Exercise Test | 26 | 2023 | 122 | 4.590 |
Why?
|
Cardiorespiratory Fitness | 10 | 2022 | 16 | 4.400 |
Why?
|
General Surgery | 13 | 2020 | 49 | 4.160 |
Why?
|
Gastroplasty | 11 | 2014 | 21 | 3.320 |
Why?
|
Veterans | 9 | 2023 | 63 | 3.200 |
Why?
|
Obesity, Morbid | 9 | 2014 | 73 | 2.520 |
Why?
|
Exercise | 13 | 2022 | 468 | 2.470 |
Why?
|
Cardiovascular Diseases | 9 | 2023 | 402 | 2.120 |
Why?
|
Exercise Tolerance | 13 | 2021 | 33 | 1.940 |
Why?
|
Forests | 11 | 2022 | 11 | 1.820 |
Why?
|
Internship and Residency | 6 | 2021 | 211 | 1.730 |
Why?
|
Models, Biological | 11 | 2021 | 343 | 1.730 |
Why?
|
Heart Failure | 5 | 2017 | 202 | 1.640 |
Why?
|
Humans | 106 | 2023 | 29337 | 1.630 |
Why?
|
Retrospective Studies | 44 | 2022 | 3273 | 1.510 |
Why?
|
Male | 78 | 2023 | 15621 | 1.490 |
Why?
|
Adult | 52 | 2023 | 8601 | 1.370 |
Why?
|
Middle Aged | 65 | 2021 | 9823 | 1.360 |
Why?
|
Risk Factors | 27 | 2023 | 2443 | 1.360 |
Why?
|
Quality of Life | 4 | 2021 | 662 | 1.350 |
Why?
|
Seeds | 6 | 2023 | 7 | 1.340 |
Why?
|
Clinical Clerkship | 5 | 2015 | 22 | 1.300 |
Why?
|
Aged | 55 | 2021 | 9448 | 1.300 |
Why?
|
Postoperative Complications | 18 | 2017 | 957 | 1.300 |
Why?
|
Female | 72 | 2021 | 16197 | 1.270 |
Why?
|
Pinus | 4 | 2018 | 4 | 1.230 |
Why?
|
Educational Measurement | 4 | 2015 | 59 | 1.170 |
Why?
|
Image-Guided Biopsy | 2 | 2018 | 26 | 1.150 |
Why?
|
Biomass | 4 | 2022 | 4 | 1.120 |
Why?
|
Smoking | 5 | 2019 | 194 | 1.090 |
Why?
|
United States | 21 | 2022 | 2333 | 1.090 |
Why?
|
Risk Assessment | 17 | 2022 | 679 | 1.070 |
Why?
|
Oxygen Consumption | 11 | 2021 | 49 | 1.030 |
Why?
|
Stomach Neoplasms | 3 | 2017 | 30 | 1.030 |
Why?
|
Plants | 5 | 2023 | 9 | 0.990 |
Why?
|
Hyperlipidemias | 1 | 2023 | 19 | 0.940 |
Why?
|
Dyslipidemias | 1 | 2023 | 23 | 0.920 |
Why?
|
Gastrointestinal Stromal Tumors | 2 | 2017 | 8 | 0.910 |
Why?
|
Weight Loss | 7 | 2014 | 99 | 0.910 |
Why?
|
Students, Medical | 2 | 2013 | 46 | 0.910 |
Why?
|
Follow-Up Studies | 22 | 2019 | 1830 | 0.890 |
Why?
|
Physical Fitness | 7 | 2021 | 59 | 0.880 |
Why?
|
Treatment Outcome | 29 | 2022 | 3478 | 0.880 |
Why?
|
Clinical Competence | 5 | 2020 | 230 | 0.880 |
Why?
|
Physicians | 2 | 2021 | 115 | 0.840 |
Why?
|
Predictive Value of Tests | 16 | 2019 | 521 | 0.830 |
Why?
|
Plant Dispersal | 3 | 2021 | 3 | 0.820 |
Why?
|
Herniorrhaphy | 7 | 2016 | 27 | 0.810 |
Why?
|
Climate Change | 5 | 2022 | 6 | 0.800 |
Why?
|
Spondylolisthesis | 1 | 2022 | 51 | 0.790 |
Why?
|
Hypertension | 3 | 2021 | 266 | 0.780 |
Why?
|
Surgeons | 1 | 2021 | 76 | 0.760 |
Why?
|
Birds | 1 | 2020 | 7 | 0.750 |
Why?
|
Hernia, Hiatal | 3 | 2014 | 11 | 0.740 |
Why?
|
Proportional Hazards Models | 10 | 2019 | 340 | 0.740 |
Why?
|
Societies, Medical | 1 | 2021 | 190 | 0.740 |
Why?
|
Spinal Diseases | 1 | 2022 | 150 | 0.740 |
Why?
|
Renal Dialysis | 1 | 2021 | 113 | 0.740 |
Why?
|
Heart Rate | 5 | 2019 | 142 | 0.730 |
Why?
|
Postoperative Hemorrhage | 1 | 2019 | 24 | 0.710 |
Why?
|
Hernia, Ventral | 4 | 2016 | 17 | 0.700 |
Why?
|
Fibrinolytic Agents | 1 | 2019 | 56 | 0.700 |
Why?
|
Prospective Studies | 12 | 2023 | 1811 | 0.700 |
Why?
|
Kidney Failure, Chronic | 1 | 2021 | 161 | 0.680 |
Why?
|
Surgical Mesh | 4 | 2014 | 22 | 0.670 |
Why?
|
Patient Safety | 2 | 2016 | 51 | 0.670 |
Why?
|
Neoplasms | 2 | 2019 | 247 | 0.660 |
Why?
|
Surgical Procedures, Operative | 2 | 2019 | 31 | 0.650 |
Why?
|
Lymph Nodes | 2 | 2018 | 70 | 0.650 |
Why?
|
Ecology | 4 | 2022 | 5 | 0.640 |
Why?
|
Esophagogastric Junction | 1 | 2017 | 12 | 0.620 |
Why?
|
Soil | 5 | 2023 | 6 | 0.620 |
Why?
|
Carcinoma, Renal Cell | 1 | 2017 | 35 | 0.600 |
Why?
|
North America | 6 | 2022 | 38 | 0.600 |
Why?
|
Spinal Fusion | 2 | 2022 | 516 | 0.590 |
Why?
|
Forecasting | 1 | 2017 | 117 | 0.590 |
Why?
|
Mycorrhizae | 3 | 2023 | 3 | 0.590 |
Why?
|
Poaceae | 2 | 2018 | 5 | 0.590 |
Why?
|
Kidney Neoplasms | 1 | 2017 | 60 | 0.590 |
Why?
|
Biota | 3 | 2015 | 4 | 0.580 |
Why?
|
Cholecystectomy, Laparoscopic | 5 | 2015 | 35 | 0.570 |
Why?
|
Quality Indicators, Health Care | 1 | 2016 | 39 | 0.560 |
Why?
|
Plant Development | 2 | 2020 | 3 | 0.550 |
Why?
|
Altitude | 2 | 2015 | 3 | 0.550 |
Why?
|
Surveys and Questionnaires | 8 | 2021 | 1184 | 0.540 |
Why?
|
Writing | 1 | 2015 | 20 | 0.540 |
Why?
|
Quality Improvement | 6 | 2021 | 158 | 0.530 |
Why?
|
Fires | 2 | 2012 | 2 | 0.530 |
Why?
|
Hospitals | 1 | 2016 | 157 | 0.530 |
Why?
|
Population Dynamics | 6 | 2016 | 11 | 0.520 |
Why?
|
Abdominal Neoplasms | 1 | 2014 | 9 | 0.520 |
Why?
|
Continuity of Patient Care | 1 | 2015 | 28 | 0.520 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2017 | 189 | 0.510 |
Why?
|
Insurance, Health | 1 | 2014 | 22 | 0.510 |
Why?
|
Lymphoma | 1 | 2014 | 44 | 0.510 |
Why?
|
Carbon Dioxide | 2 | 2017 | 20 | 0.510 |
Why?
|
Radiography, Abdominal | 1 | 2014 | 6 | 0.500 |
Why?
|
Specialties, Surgical | 1 | 2013 | 3 | 0.480 |
Why?
|
Aptitude Tests | 1 | 2013 | 2 | 0.480 |
Why?
|
Animals, Laboratory | 1 | 2013 | 1 | 0.480 |
Why?
|
Fertility | 6 | 2023 | 20 | 0.480 |
Why?
|
Seedlings | 3 | 2018 | 5 | 0.480 |
Why?
|
Education, Medical, Undergraduate | 1 | 2013 | 30 | 0.470 |
Why?
|
Pulmonary Ventilation | 2 | 2012 | 9 | 0.460 |
Why?
|
Education, Medical | 1 | 2013 | 49 | 0.450 |
Why?
|
Databases, Factual | 10 | 2021 | 330 | 0.450 |
Why?
|
Population Density | 4 | 2018 | 7 | 0.440 |
Why?
|
Logistic Models | 10 | 2016 | 407 | 0.440 |
Why?
|
Environment | 2 | 2012 | 46 | 0.430 |
Why?
|
Motor Activity | 1 | 2014 | 369 | 0.410 |
Why?
|
Operative Time | 6 | 2019 | 80 | 0.400 |
Why?
|
Colectomy | 3 | 2016 | 19 | 0.400 |
Why?
|
Fluoroscopy | 2 | 2010 | 52 | 0.380 |
Why?
|
Pilot Projects | 5 | 2019 | 394 | 0.380 |
Why?
|
Radiography, Interventional | 1 | 2010 | 24 | 0.370 |
Why?
|
Endosonography | 2 | 2007 | 11 | 0.370 |
Why?
|
Aged, 80 and over | 15 | 2021 | 4851 | 0.370 |
Why?
|
Gastrectomy | 3 | 2017 | 24 | 0.360 |
Why?
|
Anastomosis, Roux-en-Y | 1 | 2009 | 7 | 0.360 |
Why?
|
Cholelithiasis | 1 | 2009 | 10 | 0.360 |
Why?
|
Gastric Outlet Obstruction | 1 | 2009 | 3 | 0.360 |
Why?
|
Geography | 4 | 2022 | 22 | 0.360 |
Why?
|
Cardiovascular System | 2 | 2019 | 14 | 0.360 |
Why?
|
Tropical Climate | 4 | 2021 | 4 | 0.350 |
Why?
|
Idiopathic Pulmonary Fibrosis | 2 | 2019 | 6 | 0.350 |
Why?
|
Recovery of Function | 4 | 2016 | 290 | 0.340 |
Why?
|
Animals | 10 | 2020 | 4552 | 0.340 |
Why?
|
Conservation of Natural Resources | 2 | 2021 | 4 | 0.330 |
Why?
|
Cause of Death | 4 | 2017 | 65 | 0.330 |
Why?
|
Anastomotic Leak | 2 | 2019 | 5 | 0.330 |
Why?
|
Survival Rate | 8 | 2017 | 349 | 0.320 |
Why?
|
Cardiac Rehabilitation | 3 | 2021 | 9 | 0.320 |
Why?
|
Formaldehyde | 2 | 1998 | 14 | 0.320 |
Why?
|
Omentum | 1 | 2007 | 8 | 0.320 |
Why?
|
Multivariate Analysis | 7 | 2017 | 324 | 0.320 |
Why?
|
Climate | 4 | 2022 | 6 | 0.320 |
Why?
|
Practice Patterns, Physicians' | 2 | 2021 | 132 | 0.310 |
Why?
|
Reproduction | 3 | 2023 | 12 | 0.310 |
Why?
|
Rectum | 2 | 1998 | 61 | 0.310 |
Why?
|
Obesity | 3 | 2022 | 291 | 0.310 |
Why?
|
Biological Evolution | 2 | 2018 | 23 | 0.300 |
Why?
|
Prognosis | 10 | 2019 | 840 | 0.300 |
Why?
|
Missouri | 3 | 2018 | 27 | 0.300 |
Why?
|
Liposarcoma | 1 | 2006 | 5 | 0.290 |
Why?
|
Comorbidity | 5 | 2016 | 498 | 0.290 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2006 | 31 | 0.290 |
Why?
|
Education, Medical, Graduate | 2 | 2020 | 79 | 0.290 |
Why?
|
Diffusion of Innovation | 1 | 2006 | 38 | 0.280 |
Why?
|
Biopsy, Fine-Needle | 1 | 2006 | 50 | 0.280 |
Why?
|
Education, Medical, Continuing | 1 | 2006 | 45 | 0.280 |
Why?
|
Cholecystolithiasis | 1 | 2005 | 2 | 0.280 |
Why?
|
Incidence | 2 | 2019 | 756 | 0.280 |
Why?
|
Mouthwashes | 1 | 2005 | 6 | 0.270 |
Why?
|
Pancreatic Neoplasms | 1 | 2006 | 142 | 0.260 |
Why?
|
Endoscopy | 2 | 2021 | 181 | 0.260 |
Why?
|
Time Factors | 11 | 2019 | 1616 | 0.260 |
Why?
|
Gastroesophageal Reflux | 1 | 2005 | 34 | 0.260 |
Why?
|
Triglycerides | 2 | 2023 | 41 | 0.260 |
Why?
|
Pneumonia | 3 | 2016 | 67 | 0.250 |
Why?
|
Lung | 2 | 2018 | 154 | 0.250 |
Why?
|
Deer | 1 | 2004 | 2 | 0.250 |
Why?
|
Kaplan-Meier Estimate | 6 | 2016 | 162 | 0.250 |
Why?
|
Soil Microbiology | 2 | 2021 | 3 | 0.240 |
Why?
|
Blood Pressure | 5 | 2019 | 238 | 0.240 |
Why?
|
Wood | 2 | 2022 | 2 | 0.240 |
Why?
|
Health Policy | 2 | 2021 | 50 | 0.240 |
Why?
|
Chi-Square Distribution | 6 | 2013 | 145 | 0.240 |
Why?
|
Cholesterol, HDL | 1 | 2023 | 27 | 0.240 |
Why?
|
Cholesterol, LDL | 1 | 2023 | 30 | 0.230 |
Why?
|
Cholesterol | 1 | 2023 | 50 | 0.230 |
Why?
|
Feasibility Studies | 3 | 2019 | 227 | 0.230 |
Why?
|
Movement | 1 | 2004 | 143 | 0.230 |
Why?
|
Curriculum | 2 | 2020 | 155 | 0.220 |
Why?
|
Heart Diseases | 2 | 2016 | 73 | 0.220 |
Why?
|
Adolescent | 7 | 2019 | 2279 | 0.220 |
Why?
|
Exercise Therapy | 2 | 2016 | 112 | 0.220 |
Why?
|
Peripheral Arterial Disease | 2 | 2012 | 10 | 0.210 |
Why?
|
Reproducibility of Results | 2 | 2016 | 788 | 0.210 |
Why?
|
Telemedicine | 3 | 2021 | 99 | 0.210 |
Why?
|
Species Specificity | 4 | 2016 | 70 | 0.210 |
Why?
|
Drug Prescriptions | 1 | 2021 | 35 | 0.210 |
Why?
|
Blood Transfusion | 3 | 2019 | 64 | 0.200 |
Why?
|
Regeneration | 1 | 2021 | 27 | 0.200 |
Why?
|
Carbon Sequestration | 1 | 2021 | 1 | 0.200 |
Why?
|
Ambulatory Surgical Procedures | 2 | 2015 | 74 | 0.200 |
Why?
|
Carbon | 1 | 2021 | 10 | 0.200 |
Why?
|
Computer Simulation | 2 | 2020 | 218 | 0.200 |
Why?
|
Forced Expiratory Volume | 1 | 2021 | 8 | 0.200 |
Why?
|
Propofol | 1 | 2021 | 17 | 0.200 |
Why?
|
Information Dissemination | 1 | 2021 | 23 | 0.200 |
Why?
|
Respiratory Function Tests | 2 | 2012 | 32 | 0.200 |
Why?
|
Healthy Lifestyle | 1 | 2021 | 28 | 0.200 |
Why?
|
Young Adult | 5 | 2021 | 1932 | 0.200 |
Why?
|
Delirium | 1 | 2021 | 36 | 0.190 |
Why?
|
Chest Pain | 2 | 2018 | 24 | 0.190 |
Why?
|
Health Education | 1 | 2021 | 39 | 0.190 |
Why?
|
Health Care Costs | 1 | 2021 | 70 | 0.190 |
Why?
|
ROC Curve | 2 | 2013 | 138 | 0.190 |
Why?
|
Body Mass Index | 4 | 2013 | 428 | 0.190 |
Why?
|
Biomedical Research | 1 | 2021 | 81 | 0.180 |
Why?
|
Anastomosis, Surgical | 2 | 2017 | 34 | 0.180 |
Why?
|
Smokers | 1 | 2019 | 10 | 0.180 |
Why?
|
Carcinoma | 2 | 2016 | 57 | 0.180 |
Why?
|
Simulation Training | 1 | 2020 | 34 | 0.180 |
Why?
|
Cohort Studies | 7 | 2015 | 1939 | 0.180 |
Why?
|
Hernia, Inguinal | 2 | 2016 | 16 | 0.180 |
Why?
|
Intraoperative Care | 2 | 2019 | 44 | 0.180 |
Why?
|
Arteriovenous Malformations | 1 | 2019 | 3 | 0.180 |
Why?
|
Intestinal Diseases | 1 | 2019 | 9 | 0.170 |
Why?
|
Analgesics, Opioid | 1 | 2021 | 215 | 0.170 |
Why?
|
Digestive System Surgical Procedures | 1 | 2019 | 20 | 0.170 |
Why?
|
Microbiota | 1 | 2020 | 105 | 0.170 |
Why?
|
Pulmonary Artery | 1 | 2019 | 43 | 0.170 |
Why?
|
Colonic Neoplasms | 2 | 2016 | 66 | 0.170 |
Why?
|
Pulmonary Veins | 1 | 2019 | 23 | 0.170 |
Why?
|
Hypoxia | 1 | 2019 | 60 | 0.170 |
Why?
|
Sleep | 2 | 2019 | 313 | 0.170 |
Why?
|
Ixodidae | 1 | 2018 | 1 | 0.170 |
Why?
|
Patient Satisfaction | 3 | 2013 | 295 | 0.170 |
Why?
|
Infant | 2 | 2019 | 531 | 0.170 |
Why?
|
Age Factors | 3 | 2017 | 843 | 0.160 |
Why?
|
Child, Preschool | 2 | 2019 | 642 | 0.160 |
Why?
|
Atrial Fibrillation | 2 | 2013 | 180 | 0.160 |
Why?
|
Diaphragm | 1 | 2018 | 7 | 0.160 |
Why?
|
Survival Analysis | 5 | 2015 | 298 | 0.160 |
Why?
|
Foreign-Body Migration | 1 | 2018 | 25 | 0.160 |
Why?
|
Pain, Postoperative | 1 | 2021 | 314 | 0.160 |
Why?
|
California | 4 | 2013 | 31 | 0.160 |
Why?
|
Self Report | 1 | 2019 | 218 | 0.160 |
Why?
|
Southwestern United States | 1 | 2017 | 1 | 0.160 |
Why?
|
Northwestern United States | 1 | 2017 | 3 | 0.160 |
Why?
|
Antibiosis | 1 | 2017 | 2 | 0.160 |
Why?
|
Scoliosis | 1 | 2018 | 34 | 0.160 |
Why?
|
Multimorbidity | 1 | 2017 | 8 | 0.150 |
Why?
|
Infant, Newborn | 1 | 2019 | 604 | 0.150 |
Why?
|
Nephrectomy | 1 | 2017 | 29 | 0.150 |
Why?
|
Geriatric Assessment | 1 | 2019 | 219 | 0.150 |
Why?
|
Child | 3 | 2019 | 1346 | 0.150 |
Why?
|
Cardiovascular Physiological Phenomena | 1 | 2017 | 6 | 0.150 |
Why?
|
Urinary Retention | 1 | 2017 | 12 | 0.150 |
Why?
|
Surgical Stapling | 1 | 2017 | 6 | 0.150 |
Why?
|
Electrocardiography | 3 | 2013 | 209 | 0.150 |
Why?
|
Europe | 1 | 2017 | 81 | 0.150 |
Why?
|
Mobile Applications | 1 | 2017 | 24 | 0.150 |
Why?
|
Bolivia | 2 | 2015 | 3 | 0.150 |
Why?
|
Alcoholism | 1 | 2017 | 83 | 0.150 |
Why?
|
Cytoreduction Surgical Procedures | 1 | 2016 | 6 | 0.140 |
Why?
|
Enterostomy | 1 | 2016 | 5 | 0.140 |
Why?
|
Substance-Related Disorders | 1 | 2017 | 104 | 0.140 |
Why?
|
Observer Variation | 1 | 2016 | 118 | 0.140 |
Why?
|
Secondary Prevention | 1 | 2016 | 64 | 0.140 |
Why?
|
Lumbar Vertebrae | 1 | 2022 | 487 | 0.140 |
Why?
|
Heart | 2 | 2010 | 91 | 0.140 |
Why?
|
Magnoliopsida | 1 | 2015 | 1 | 0.140 |
Why?
|
Pollination | 1 | 2015 | 1 | 0.140 |
Why?
|
Stroke Volume | 2 | 2013 | 56 | 0.140 |
Why?
|
Ventricular Function, Left | 2 | 2013 | 45 | 0.140 |
Why?
|
Hospitalization | 1 | 2019 | 317 | 0.140 |
Why?
|
Ovarian Neoplasms | 1 | 2016 | 46 | 0.140 |
Why?
|
Fundoplication | 2 | 2013 | 20 | 0.140 |
Why?
|
Coronary Artery Disease | 1 | 2017 | 123 | 0.140 |
Why?
|
Diagnosis, Differential | 2 | 2014 | 389 | 0.130 |
Why?
|
End Stage Liver Disease | 1 | 2015 | 13 | 0.130 |
Why?
|
Certification | 1 | 2015 | 49 | 0.130 |
Why?
|
Plant Physiological Phenomena | 1 | 2015 | 1 | 0.130 |
Why?
|
Job Application | 1 | 2015 | 6 | 0.130 |
Why?
|
Gastroscopy | 1 | 2015 | 8 | 0.130 |
Why?
|
Academic Medical Centers | 1 | 2016 | 142 | 0.130 |
Why?
|
Gallbladder Neoplasms | 1 | 2015 | 6 | 0.130 |
Why?
|
Gastrostomy | 1 | 2015 | 8 | 0.130 |
Why?
|
Minimally Invasive Surgical Procedures | 3 | 2014 | 300 | 0.130 |
Why?
|
Appendectomy | 1 | 2014 | 15 | 0.130 |
Why?
|
Patient Readmission | 1 | 2016 | 123 | 0.130 |
Why?
|
Environmental Monitoring | 1 | 2014 | 8 | 0.130 |
Why?
|
Medical History Taking | 1 | 2014 | 24 | 0.130 |
Why?
|
Diabetes Mellitus | 3 | 2017 | 138 | 0.130 |
Why?
|
Appendicitis | 1 | 2014 | 18 | 0.130 |
Why?
|
Quality of Health Care | 1 | 2016 | 138 | 0.130 |
Why?
|
Cardiovascular Agents | 1 | 2014 | 28 | 0.130 |
Why?
|
Program Evaluation | 2 | 2013 | 132 | 0.130 |
Why?
|
Occupational Health | 1 | 2014 | 21 | 0.130 |
Why?
|
Analysis of Variance | 3 | 2012 | 321 | 0.120 |
Why?
|
Odds Ratio | 5 | 2015 | 285 | 0.120 |
Why?
|
Credentialing | 1 | 2014 | 8 | 0.120 |
Why?
|
Biliary Dyskinesia | 1 | 2013 | 3 | 0.120 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2013 | 8 | 0.120 |
Why?
|
Intestine, Small | 1 | 2014 | 33 | 0.120 |
Why?
|
Prosthesis Failure | 1 | 2018 | 556 | 0.120 |
Why?
|
Preoperative Period | 1 | 2014 | 65 | 0.120 |
Why?
|
Walking | 1 | 2016 | 252 | 0.120 |
Why?
|
Elective Surgical Procedures | 1 | 2014 | 43 | 0.120 |
Why?
|
Rest | 1 | 2013 | 32 | 0.120 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2021 | 200 | 0.120 |
Why?
|
Gallbladder Diseases | 1 | 2013 | 5 | 0.120 |
Why?
|
Head and Neck Neoplasms | 1 | 2015 | 133 | 0.120 |
Why?
|
Cholecystectomy | 1 | 2013 | 16 | 0.120 |
Why?
|
Heart Failure, Systolic | 1 | 2013 | 3 | 0.120 |
Why?
|
Abdominal Wall | 1 | 2013 | 4 | 0.110 |
Why?
|
Quercus | 1 | 2012 | 1 | 0.110 |
Why?
|
Carya | 1 | 2012 | 1 | 0.110 |
Why?
|
Severity of Illness Index | 1 | 2017 | 1113 | 0.110 |
Why?
|
Disease-Free Survival | 1 | 2013 | 175 | 0.110 |
Why?
|
Health Promotion | 1 | 2014 | 161 | 0.110 |
Why?
|
Sepsis | 1 | 2014 | 144 | 0.110 |
Why?
|
Louisiana | 1 | 2012 | 1 | 0.110 |
Why?
|
Flowers | 1 | 2012 | 1 | 0.110 |
Why?
|
Registries | 3 | 2021 | 188 | 0.110 |
Why?
|
Anxiety | 1 | 2013 | 152 | 0.110 |
Why?
|
Case-Control Studies | 3 | 2013 | 638 | 0.110 |
Why?
|
Postoperative Care | 1 | 2012 | 127 | 0.110 |
Why?
|
Foreign Bodies | 1 | 1992 | 25 | 0.110 |
Why?
|
Esophageal Achalasia | 1 | 2012 | 19 | 0.110 |
Why?
|
Sensitivity and Specificity | 3 | 2008 | 553 | 0.100 |
Why?
|
Ileal Neoplasms | 1 | 2011 | 1 | 0.100 |
Why?
|
Recreation | 1 | 2011 | 3 | 0.100 |
Why?
|
Esophagus | 1 | 2012 | 59 | 0.100 |
Why?
|
Health Status | 1 | 2012 | 227 | 0.100 |
Why?
|
Water | 1 | 2011 | 34 | 0.100 |
Why?
|
Illinois | 2 | 2014 | 241 | 0.100 |
Why?
|
Reoperation | 3 | 2016 | 932 | 0.100 |
Why?
|
Reference Standards | 2 | 2021 | 33 | 0.100 |
Why?
|
Stress, Psychological | 1 | 2013 | 246 | 0.100 |
Why?
|
Adrenergic beta-Antagonists | 2 | 2010 | 42 | 0.100 |
Why?
|
Phylogeny | 2 | 2021 | 63 | 0.100 |
Why?
|
Length of Stay | 4 | 2014 | 317 | 0.100 |
Why?
|
Demography | 1 | 2011 | 77 | 0.100 |
Why?
|
Melanoma | 1 | 2011 | 52 | 0.100 |
Why?
|
Skin Neoplasms | 1 | 2011 | 65 | 0.100 |
Why?
|
Coronary Circulation | 1 | 2010 | 43 | 0.090 |
Why?
|
Upper Gastrointestinal Tract | 1 | 2010 | 1 | 0.090 |
Why?
|
Methylene Blue | 1 | 2010 | 2 | 0.090 |
Why?
|
Duodenostomy | 1 | 2009 | 1 | 0.090 |
Why?
|
Jejunostomy | 1 | 2009 | 6 | 0.090 |
Why?
|
Conscious Sedation | 1 | 2009 | 6 | 0.090 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2010 | 75 | 0.090 |
Why?
|
Safety | 1 | 2009 | 45 | 0.090 |
Why?
|
Neutropenia | 1 | 2008 | 21 | 0.080 |
Why?
|
Myocardial Perfusion Imaging | 1 | 2010 | 57 | 0.080 |
Why?
|
Ambulatory Care Facilities | 1 | 2009 | 37 | 0.080 |
Why?
|
Stomach Diseases | 1 | 2008 | 2 | 0.080 |
Why?
|
Pancreatic Cyst | 1 | 2008 | 3 | 0.080 |
Why?
|
Models, Theoretical | 2 | 2021 | 91 | 0.080 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2008 | 38 | 0.080 |
Why?
|
Administration, Rectal | 2 | 1998 | 6 | 0.080 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 2007 | 9 | 0.080 |
Why?
|
Ischemia | 1 | 2007 | 27 | 0.080 |
Why?
|
Surgical Instruments | 1 | 2007 | 25 | 0.080 |
Why?
|
Bile Ducts | 1 | 2007 | 12 | 0.080 |
Why?
|
Temperature | 2 | 2022 | 76 | 0.080 |
Why?
|
Dogs | 2 | 1998 | 253 | 0.080 |
Why?
|
Splenectomy | 1 | 2006 | 6 | 0.070 |
Why?
|
Pancreatectomy | 1 | 2006 | 10 | 0.070 |
Why?
|
Stomach | 1 | 2006 | 18 | 0.070 |
Why?
|
Pancreas | 1 | 2006 | 32 | 0.070 |
Why?
|
Sleep Apnea Syndromes | 1 | 2006 | 33 | 0.070 |
Why?
|
Prostaglandins F, Synthetic | 1 | 2005 | 2 | 0.070 |
Why?
|
Glaucoma | 1 | 2005 | 4 | 0.070 |
Why?
|
Intestinal Mucosa | 2 | 1998 | 220 | 0.070 |
Why?
|
Intraocular Pressure | 1 | 2005 | 6 | 0.070 |
Why?
|
Intestines | 2 | 2017 | 107 | 0.070 |
Why?
|
Research Design | 1 | 2007 | 212 | 0.070 |
Why?
|
Blood Glucose | 2 | 2019 | 112 | 0.060 |
Why?
|
Antihypertensive Agents | 1 | 2005 | 85 | 0.060 |
Why?
|
Confidence Intervals | 2 | 2015 | 96 | 0.060 |
Why?
|
Plants, Edible | 1 | 2004 | 2 | 0.060 |
Why?
|
Territoriality | 1 | 2004 | 2 | 0.060 |
Why?
|
Surgical Wound Infection | 2 | 2016 | 97 | 0.060 |
Why?
|
Prostheses and Implants | 1 | 2005 | 166 | 0.060 |
Why?
|
Symbiosis | 1 | 2023 | 5 | 0.060 |
Why?
|
Satiation | 1 | 2023 | 2 | 0.060 |
Why?
|
Feedback | 1 | 2023 | 31 | 0.060 |
Why?
|
Feeding Behavior | 1 | 2004 | 100 | 0.060 |
Why?
|
Plant Leaves | 1 | 2022 | 3 | 0.060 |
Why?
|
Recurrence | 2 | 2014 | 350 | 0.060 |
Why?
|
Microclimate | 1 | 2022 | 1 | 0.050 |
Why?
|
Sex Factors | 2 | 2016 | 496 | 0.050 |
Why?
|
Uncertainty | 1 | 2022 | 8 | 0.050 |
Why?
|
South America | 1 | 2021 | 4 | 0.050 |
Why?
|
Reference Values | 1 | 2021 | 227 | 0.050 |
Why?
|
Spinal Cord Injuries | 1 | 2002 | 47 | 0.050 |
Why?
|
Phenotype | 1 | 2022 | 355 | 0.050 |
Why?
|
Anesthesia, Intravenous | 1 | 2021 | 8 | 0.050 |
Why?
|
Respiratory Tract Diseases | 1 | 2021 | 6 | 0.050 |
Why?
|
Organizational Policy | 1 | 2021 | 15 | 0.050 |
Why?
|
Rehabilitation | 1 | 2021 | 14 | 0.050 |
Why?
|
Seasons | 1 | 2021 | 31 | 0.050 |
Why?
|
Anesthesia, General | 1 | 2021 | 30 | 0.050 |
Why?
|
Rhizosphere | 1 | 2020 | 1 | 0.050 |
Why?
|
Endophytes | 1 | 2020 | 1 | 0.050 |
Why?
|
Grassland | 1 | 2020 | 1 | 0.050 |
Why?
|
Plant Roots | 1 | 2020 | 4 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 2 | 2018 | 770 | 0.050 |
Why?
|
Risk Reduction Behavior | 1 | 2021 | 55 | 0.050 |
Why?
|
Smoking Cessation | 1 | 2021 | 50 | 0.050 |
Why?
|
Transforming Growth Factor alpha | 1 | 2000 | 6 | 0.050 |
Why?
|
Lymphokines | 1 | 2000 | 9 | 0.050 |
Why?
|
Endothelial Growth Factors | 1 | 2000 | 6 | 0.050 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2020 | 56 | 0.050 |
Why?
|
Electroencephalography | 1 | 2021 | 140 | 0.050 |
Why?
|
Carbon Cycle | 1 | 2019 | 1 | 0.050 |
Why?
|
Bacteria | 1 | 2020 | 77 | 0.050 |
Why?
|
Oximetry | 1 | 2019 | 11 | 0.050 |
Why?
|
Isoxazoles | 1 | 1999 | 16 | 0.050 |
Why?
|
International Cooperation | 1 | 2019 | 32 | 0.050 |
Why?
|
Adjuvants, Immunologic | 1 | 1999 | 26 | 0.050 |
Why?
|
Neovascularization, Pathologic | 1 | 2000 | 56 | 0.050 |
Why?
|
Healthy Volunteers | 1 | 2019 | 46 | 0.050 |
Why?
|
Esophageal Neoplasms | 1 | 2000 | 45 | 0.050 |
Why?
|
Patient Education as Topic | 1 | 2021 | 162 | 0.040 |
Why?
|
Smartphone | 1 | 2019 | 15 | 0.040 |
Why?
|
United Kingdom | 1 | 2019 | 50 | 0.040 |
Why?
|
Evidence-Based Practice | 1 | 2019 | 77 | 0.040 |
Why?
|
Biomarkers, Tumor | 1 | 2000 | 175 | 0.040 |
Why?
|
Chronic Disease | 1 | 2021 | 495 | 0.040 |
Why?
|
Nymph | 1 | 2018 | 1 | 0.040 |
Why?
|
Larva | 1 | 2018 | 3 | 0.040 |
Why?
|
Hemoptysis | 1 | 2018 | 8 | 0.040 |
Why?
|
Southeastern United States | 1 | 2018 | 9 | 0.040 |
Why?
|
Proctitis | 1 | 1998 | 3 | 0.040 |
Why?
|
Compliance | 1 | 1998 | 6 | 0.040 |
Why?
|
Radiography, Thoracic | 1 | 2018 | 28 | 0.040 |
Why?
|
Manometry | 1 | 1998 | 18 | 0.040 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 1998 | 22 | 0.040 |
Why?
|
Radiation Injuries | 1 | 1998 | 34 | 0.040 |
Why?
|
Collagen | 1 | 1998 | 102 | 0.040 |
Why?
|
Lymph Node Excision | 2 | 2015 | 26 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 1999 | 218 | 0.040 |
Why?
|
Coronary Angiography | 1 | 2017 | 91 | 0.040 |
Why?
|
Kinetics | 1 | 2017 | 225 | 0.040 |
Why?
|
Tobacco Smoking | 1 | 2016 | 4 | 0.040 |
Why?
|
Tuberculosis, Pulmonary | 1 | 1976 | 8 | 0.040 |
Why?
|
Peripheral Vascular Diseases | 1 | 2016 | 9 | 0.040 |
Why?
|
Angina Pectoris | 1 | 2016 | 17 | 0.040 |
Why?
|
Satellite Imagery | 1 | 2016 | 1 | 0.040 |
Why?
|
Remote Sensing Technology | 1 | 2016 | 2 | 0.040 |
Why?
|
Equipment Design | 1 | 2017 | 185 | 0.040 |
Why?
|
Cholangiography | 1 | 2015 | 11 | 0.030 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2016 | 42 | 0.030 |
Why?
|
Ambulatory Care | 1 | 2016 | 75 | 0.030 |
Why?
|
Hernia, Umbilical | 1 | 2015 | 2 | 0.030 |
Why?
|
Spatial Analysis | 1 | 2015 | 1 | 0.030 |
Why?
|
Least-Squares Analysis | 1 | 2015 | 8 | 0.030 |
Why?
|
Life Style | 1 | 2017 | 211 | 0.030 |
Why?
|
Perioperative Care | 1 | 2015 | 52 | 0.030 |
Why?
|
Ultrasonography, Interventional | 1 | 2015 | 63 | 0.030 |
Why?
|
Morbidity | 1 | 2014 | 63 | 0.030 |
Why?
|
Workplace | 1 | 2014 | 18 | 0.030 |
Why?
|
Attitude of Health Personnel | 1 | 2015 | 148 | 0.030 |
Why?
|
Patient Protection and Affordable Care Act | 1 | 2014 | 22 | 0.030 |
Why?
|
Hepatectomy | 1 | 2015 | 55 | 0.030 |
Why?
|
Regression Analysis | 1 | 2015 | 298 | 0.030 |
Why?
|
Disease Models, Animal | 1 | 1997 | 724 | 0.030 |
Why?
|
Colonic Diseases | 1 | 2014 | 12 | 0.030 |
Why?
|
Breath Tests | 1 | 2013 | 11 | 0.030 |
Why?
|
Hospital Mortality | 1 | 2015 | 141 | 0.030 |
Why?
|
Echocardiography, Doppler | 1 | 2013 | 19 | 0.030 |
Why?
|
Neoplasm Staging | 1 | 2015 | 340 | 0.030 |
Why?
|
Patient-Centered Care | 1 | 2014 | 62 | 0.030 |
Why?
|
Referral and Consultation | 1 | 2014 | 86 | 0.030 |
Why?
|
Prosthesis Implantation | 1 | 2013 | 33 | 0.030 |
Why?
|
Wound Healing | 1 | 2014 | 168 | 0.030 |
Why?
|
Disease Management | 1 | 2014 | 114 | 0.030 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2013 | 104 | 0.030 |
Why?
|
Hospitals, Veterans | 1 | 2012 | 6 | 0.030 |
Why?
|
Phylogeography | 1 | 2012 | 1 | 0.030 |
Why?
|
Anticoagulants | 1 | 2013 | 100 | 0.030 |
Why?
|
Italy | 1 | 2012 | 16 | 0.030 |
Why?
|
Systole | 1 | 2012 | 18 | 0.030 |
Why?
|
Retroperitoneal Space | 1 | 1992 | 12 | 0.030 |
Why?
|
Heart Transplantation | 1 | 2012 | 38 | 0.030 |
Why?
|
Heart-Assist Devices | 1 | 2012 | 22 | 0.030 |
Why?
|
Laparoscopes | 1 | 2011 | 2 | 0.030 |
Why?
|
Ankle Brachial Index | 1 | 2011 | 6 | 0.030 |
Why?
|
Hemostasis, Surgical | 1 | 1991 | 15 | 0.030 |
Why?
|
Prostatectomy | 1 | 1991 | 18 | 0.030 |
Why?
|
Vascular Surgical Procedures | 1 | 2011 | 24 | 0.030 |
Why?
|
Biopsy, Needle | 1 | 2011 | 101 | 0.020 |
Why?
|
Hemorrhage | 1 | 1991 | 75 | 0.020 |
Why?
|
Hot Temperature | 1 | 2010 | 23 | 0.020 |
Why?
|
Intraoperative Complications | 1 | 1991 | 68 | 0.020 |
Why?
|
District of Columbia | 1 | 2010 | 5 | 0.020 |
Why?
|
BCG Vaccine | 1 | 1990 | 2 | 0.020 |
Why?
|
Carcinoma in Situ | 1 | 1990 | 9 | 0.020 |
Why?
|
Carcinoma, Transitional Cell | 1 | 1990 | 12 | 0.020 |
Why?
|
Switzerland | 1 | 2010 | 9 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2011 | 391 | 0.020 |
Why?
|
Urinary Bladder Neoplasms | 1 | 1990 | 26 | 0.020 |
Why?
|
Prevalence | 1 | 2011 | 487 | 0.020 |
Why?
|
Education, Professional | 1 | 2009 | 6 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 1990 | 184 | 0.020 |
Why?
|
Equipment and Supplies | 1 | 2009 | 14 | 0.020 |
Why?
|
Documentation | 1 | 2009 | 31 | 0.020 |
Why?
|
Pharmaceutical Preparations | 1 | 2009 | 21 | 0.020 |
Why?
|
Quality Assurance, Health Care | 1 | 2009 | 49 | 0.020 |
Why?
|
Teaching | 1 | 2009 | 62 | 0.020 |
Why?
|
Mortality | 1 | 2009 | 86 | 0.020 |
Why?
|
Disability Evaluation | 1 | 2010 | 327 | 0.020 |
Why?
|
Cysts | 1 | 2008 | 16 | 0.020 |
Why?
|
Emergencies | 1 | 2008 | 39 | 0.020 |
Why?
|
Community-Acquired Infections | 1 | 2008 | 78 | 0.020 |
Why?
|
Biomarkers | 1 | 2011 | 689 | 0.020 |
Why?
|
Device Removal | 1 | 2008 | 85 | 0.020 |
Why?
|
Patient Selection | 1 | 2009 | 232 | 0.020 |
Why?
|
Monitoring, Intraoperative | 1 | 2007 | 37 | 0.020 |
Why?
|
Cross-Sectional Studies | 1 | 2010 | 959 | 0.020 |
Why?
|
Patient Participation | 1 | 2005 | 52 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2005 | 324 | 0.010 |
Why?
|
Trauma Severity Indices | 1 | 2002 | 9 | 0.010 |
Why?
|
Thoracic Vertebrae | 1 | 2002 | 111 | 0.010 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2000 | 9 | 0.010 |
Why?
|
von Willebrand Factor | 1 | 2000 | 12 | 0.010 |
Why?
|
Barrett Esophagus | 1 | 2000 | 11 | 0.010 |
Why?
|
Esophagectomy | 1 | 2000 | 21 | 0.010 |
Why?
|
Pyrimidine Nucleotides | 1 | 1999 | 1 | 0.010 |
Why?
|
Receptors, Platelet-Derived Growth Factor | 1 | 1999 | 1 | 0.010 |
Why?
|
Receptors, Growth Factor | 1 | 1999 | 2 | 0.010 |
Why?
|
Crotonates | 1 | 1999 | 3 | 0.010 |
Why?
|
Toluidines | 1 | 1999 | 3 | 0.010 |
Why?
|
3T3 Cells | 1 | 1999 | 11 | 0.010 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 1999 | 14 | 0.010 |
Why?
|
Neoplasm Transplantation | 1 | 1999 | 23 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2000 | 138 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2000 | 65 | 0.010 |
Why?
|
Mice, Nude | 1 | 1999 | 33 | 0.010 |
Why?
|
Tyrosine | 1 | 1999 | 23 | 0.010 |
Why?
|
Hydroxybutyrates | 1 | 1999 | 5 | 0.010 |
Why?
|
Nitriles | 1 | 1999 | 13 | 0.010 |
Why?
|
Lymphatic Metastasis | 1 | 2000 | 81 | 0.010 |
Why?
|
Cell Division | 1 | 1999 | 113 | 0.010 |
Why?
|
Aniline Compounds | 1 | 1999 | 41 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 1999 | 145 | 0.010 |
Why?
|
Glioma | 1 | 1999 | 47 | 0.010 |
Why?
|
Phosphorylation | 1 | 1999 | 159 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 1999 | 263 | 0.010 |
Why?
|
ErbB Receptors | 1 | 1999 | 72 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 1999 | 132 | 0.010 |
Why?
|
Carcinoma, Squamous Cell | 1 | 1999 | 178 | 0.010 |
Why?
|
History of Medicine | 1 | 1976 | 1 | 0.010 |
Why?
|
Tuberculosis, Bovine | 1 | 1976 | 1 | 0.010 |
Why?
|
Hospitals, Special | 1 | 1976 | 6 | 0.010 |
Why?
|
Cattle | 1 | 1976 | 217 | 0.010 |
Why?
|
Mice | 1 | 1999 | 1607 | 0.010 |
Why?
|
Hematocrit | 1 | 1991 | 11 | 0.010 |
Why?
|
Pelvis | 1 | 1991 | 30 | 0.010 |
Why?
|
Administration, Intravesical | 1 | 1990 | 5 | 0.010 |
Why?
|
Prostatic Neoplasms | 1 | 1991 | 106 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 1990 | 223 | 0.010 |
Why?
|
Adenocarcinoma | 1 | 1991 | 189 | 0.010 |
Why?
|